SOLAR-PROMOTION
28.5.2024 10:42:32 CEST | Business Wire | Press release
Visitors to The smarter E Europe, Europe’s Largest Alliance of Exhibitions for the Energy Industry, will find out how private consumers can become self-sufficient in electricity, heat and transport in a smart way and how this creates new business opportunities for installers and system providers. The smarter E Europe combines the four trade fairs Intersolar Europe, ees Europe, Power2Drive Europe and EM-Power Europe and takes place from June 19 to 21 at Messe München. Around 3,000 exhibitors and more than 115,000 visitors from all over the world are expected in 19 exhibition halls and on an outdoor area.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240528827105/en/
The smarter E Europe shows interplay of components. ©Solar Promotion GmbH
There are around 19.3 million residential buildings in Germany. More than half of these will need to be renovated and equipped with photovoltaics over the next 20 years. But residential buildings also play a central role in solar expansion throughout Europe. Everywhere, solar systems are being installed with storage systems, as this allows the solar power generated to be used as needed.
Increasing electrification in the transport and heating sectors
Solar power has been generated and stored to supply the home, but what else can it be used for? For the increasingly popular electric car. In the home system, battery electric vehicles as well as heat pumps can be charged and operated cost-effectively and climate-neutrally with the solar power. In Germany, 51 percent more heat pumps were sold last year than in 2022. With the adoption of the EU Heat Pump Action Plan, this development will continue dynamically. The combination of PV, a storage system, electric car and heat pump forms an effective network of electricity-generating, electricity-storing and electricity-consuming units.
An interplay of components and trade disciplines
The industry offers a wide range of components - from PV systems and intelligent wall boxes to smart meters and much more. However, successfully building a comprehensive energy system requires not only interaction between the individual components, but also smooth cooperation between the electrical trade, plumbing, heating and air conditioning technology (HVAC) and other trades.
Optimize self-consumption, relieve the grid
The electricity system requires a high degree of flexibility in order to be able to provide a renewable energy supply 24/7. Flexible small consumers with their own home energy systems can make a major contribution to keeping electricity generation and consumption in balance while optimizing their own consumption at low cost.
Dynamic electricity tariffs: Supply meets demand
Dynamic electricity tariffs are another way of better coordinating supply and demand. Consumers base their consumption on the current electricity prices, which change depending on supply and demand. From 2025, all electricity suppliers in Germany will be obliged to offer their customers a dynamic electricity tariff. Prerequisite for this is the installation of a smart meter.
The smarter E Europe
"Accelerating Integrated Energy Solutions" - under this motto, The smarter E Europe, Europe's largest trade fair alliance for the energy industry, focuses on cross-industry solutions for a 24/7 renewable energy supply in the electricity, heating and transport sectors. The smarter E Europe combines four trade fairs and will take place from June 19-21, 2024 at Messe München.
Further information: www.TheSmarterE.de
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240528827105/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
LTM Launches BlueVerse™ for iRun to Outcreate Managed Services in the Agentic AI Era15.6.2026 08:10:00 CEST | Press release
AI-native operations model enables enterprises to move from reactive service delivery to intelligent, outcome-driven managed services LTM, the Business Creativity partner to the world’s largest enterprises, today announced the launch of BlueVerse™ for iRun, an AI-native managed services model designed to transform traditional IT operations into a resilient, intelligent, and outcome-driven operating model. As enterprise environments grow more complex—spanning hybrid cloud, SaaS, and AI-driven ecosystems—traditional managed services models are increasingly constrained by siloed teams, static processes, and effort-led scaling. BlueVerse for iRun addresses this shift by moving beyond headcount-based delivery to a platform-led approach powered by agentic AI, knowledge convergence, and process-as-code. Built on the BlueVerse ecosystem, iRun creates a unified intelligence layer that brings together enterprise data, telemetry, workflows, and operational context—enabling AI to reason across sys
Azafaros to Present at BIO International Convention 202615.6.2026 07:00:00 CEST | Press release
Azafaros, a private company building a portfolio to become a leader in lysosomal storage disorders (LSDs), focused on addressing neurological symptoms, today announced that it will present at the 2026 BIO International Convention taking place in San Diego, USA, from June 22-25. The company’s presentation is scheduled for Monday, June 22 at 4:30 PM in Theater 4. The presentation will highlight Azafaros’ progress in developing nizubaglustat, its lead investigational compound for the treatment of rare lysosomal storage disorders with neurological involvement, including GM1 and GM2 gangliosidoses (GM1/GM2) and Niemann-Pick type C disease (NPC). Nizubaglustat is currently in two Phase 3 registrational studies (NAVIGATE) treating patients with GM1/GM2 and NPC and expects to report topline data from the studies in 2028. “BIO provides an important opportunity to update our progress as we continue advancing nizubaglustat through late-stage clinical development,” said Stefano Portolano, CEO at A
Teledyne FLIR Defense Launches Black Recon™ Autonomous Micro-Drone15.6.2026 06:05:00 CEST | Press release
Autonomous launch, recovery, and recharge from military vehicles and fixed installations; Three-drone rotation provides persistent surveillance and real-time targeting data in contested environments Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE: TDY), today announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone system that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260614388428/en/ Teledyne FLIR Defense announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. Black Recon allows crews to launch, operate, recover, and recharge up to three UAS without leaving their platform, reducing operator risk. Designed for vehicle integrati
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom